IQVIA™ Real-World Insights Bibliography

HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH PERSISTENT ASTHMA BY ATTAINMENT OF HEALTHCARE EFFECTIVENESS AND DATA INFORMATION SET (HEDIS) MEASURES
Author(s): Mosnaim G, Ariely R, Depietro M, Near A, Huang H, Batista A, Lang K
Affiliations(s): Huan Huang and Aimee Near are at IQVIA
Publication(s):  ISPOR
Document Type(s): Poster,
Countries: USA,
Click here for the abstract
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Population Based Study,
  Add to report
 
 
Patients with idiopathic pulmonary fibrosis (IPF): what happens before the diagnosis? A real-world, retrospective, primary care database analysis
Author(s): Cipelli R1, Heiman F1, Acciai V2, Berardo P2, Olivi I2
Affiliations(s): 1 IQVIA, RWI, Milan, Italy 2 Boehringer Ingelheim Italia S.p.A, Milan, Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
A cost estimation of management of allergic asthma in Italy
Author(s): Ariemma F1, Trimarchi C1, Canonica GW2, Senna G3, Scichilone N4, Pelaia G5, Paggiaro P6, Griffiths S7, Urbinati D1
Affiliations(s): 1 IQVIA, RWI, Milan, Italy 2 Humanitas Research Hospital, Milan, Italy 3 Azienda Ospedaliera Universitaria Integrata, Verona Italy 4 Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy 5 Azienda Ospedaliera Universitaria Mater Domini, Catanzaro, Italy 6 Azienda Ospedaliero Universitaria, Pisa, Italy 7 Alk Abellò, Milan Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Cost analysis, Real World Data, Real World Evidence, Retrospective cohort analysis,
  Add to report
 
 
A RETROSPECTIVE DATABASE STUDY TO DEFINE A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT AND EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN FRANCE
Author(s): Petrica N (1), Beaudier E(1),Exposto F (2), Beaudet A(3)
Affiliations(s): (1) IQVIA, Paris France (2) IQVIA, London UK (3) Actelion Pharmaceuticals Ltd, Switzerland
Publication(s):  ISPOR 2018
Document Type(s): Article, Poster,
Countries: France,
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Cost analysis, Cost of illness, Retrospective database analysis,
  Add to report
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Author(s): Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China
Publication(s): 
Document Type(s): Poster,
Countries: China,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost analysis, Cost effectiveness,
  Add to report
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Author(s): Salem A, Ramos M, Hu H, Zhong H, Lamotte M
Affiliations(s): IQVIA, Zaventem, Belgium
Publication(s):  ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan
Document Type(s): Poster,
Countries: China,
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
The cost-effectiveness of physical activity in the management of COPD patients in the UK.
Author(s): Ramos M, Lamotte M, Gerlier L, Svangren P, Cases A M, Haughney J
Affiliations(s): IQVIA, Zaventem, Belgium
Publication(s): 
Document Type(s): Poster,
Countries: UK,
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Longitudinal Study of Patient Profile and Treatment Patterns of Omalizumab in Patients with Asthma Refractory to Inhaled Medications
Author(s): Jason K. Lee 1, Suvina Amin 2, Michelle Erdmann 2, Atif Kukaswadia 3, Jelena Ivanovic 3, Aren Fischer 3, Alain Gendron 2,4
Affiliations(s): 1 Evidence Based Medical Educator Inc. Toronto, On, Canada and Section Head of Asthma at Canadian Society of Allergy and Clinical Immunology; 2 AstraZeneca, Mississauga, ON, Canada; 3 IQVIA, Toronto, ON, Canada; 4 Department of medicine, University of Montreal, Montreal, Canada
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Respiratory disease,
2018
  L:
A:
English
Longitudinal study, Retrospective cohort analysis,
  Add to report
 
 
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
Author(s): Rito Bergemann, James Allsopp, Harvey Jenner, Flora Ashley Daniels, Edmund Drage, Yevgeniy Samyshkin, Claude Schmitt, Steven Wood, David G. Kiely, Allan Lawrie
Affiliations(s): "1GlaxoSmithKline, Brentford, Middlesex, UK 2Current affiliation: Evalueserve Life Sciences Healthcare, London, UK 3Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK 4IQVIA, London, UK 5Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 6National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK 7INSIGNEO, University of Sheffield, Sheffield, UK"
Publication(s): 
Document Type(s): Article,
Countries: UK,
C:
Y:
Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension
Author(s): "David G. Kiely MD, Allan Lawrie, Orla Doyle PhD, Valentina Salvatelli PhD, Flora Ashley Daniels PhD, Edmund Drage, Harvey Jenner, John Rigg, Claude Schmitt, Yevgeniy Samyshkin, Rito Bergemann "
Affiliations(s): 1Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK; 2Real-World & Analytical Solutions, IQVIA, London, UK; 3GSK, Brentford, Middlesex, UK; 4Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK; 5INSIGNEO, University of Sheffield, Sheffield, UK; 6Evalueserve UK Ltd, London, UK. 1 Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK. 2 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. 3 INSIGNEO, University of Sheffield, Sheffield, UK. 4 Real-World & Analytical Solutions, IQVIA, London, UK. 5 GlaxoSmithKline, Brentford, Middlesex, UK.
Publication(s): 
Document Type(s): Poster,
Countries: UK,
C:
Y:
Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
 1 of 24 Next Page Last Page